Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol Moreno

Showing results (101-110 of 167) with videos related to

Pageof 17
Sort By:
Transplantation and Cellular Therapy|November 10, 2021
Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and ChallengesSara Redondo, Albert Esquirol, Silvana Novelli, et al.
Physiological Genomics|June 20, 2013
SORCS1 contributes to the development of renal disease in rats and humansJozef Lazar, Caitlin C O'Meara, Allison B Sarkis, et al.
American Journal of Physiology. Renal Physiology|July 22, 2016
Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney diseaseMarcela Herrera, Magnus Söderberg, Alan Sabirsh, et al.
Journal of Cancer Research and Clinical Oncology|August 31, 2019
Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioningNiels Smedegaard Andersen, Martin Bornhäuser, Martin Gramatzki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
Mutation of Plekha7 attenuates salt-sensitive hypertension in the ratBradley T Endres, Jessica R C Priestley, Oleg Palygin, et al.
American Journal of Physiology. Renal Physiology|October 10, 2008
Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injuryJan Michael Williams, Albert Sarkis, Kimberly M Hoagland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2023
B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib TherapyJennifer A Woyach, Paolo Ghia, John C Byrd, et al.
Circulation. Cardiovascular Genetics|January 29, 2015
SH2B3 Is a Genetic Determinant of Cardiac Inflammation and FibrosisMichael J Flister, Matthew J Hoffman, Angela Lemke, et al.
European Journal of Immunology|June 20, 2006
IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptorsChrysoula J Belessi, Frédéric B Davi, Kostas E Stamatopoulos, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 19, 2018
Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to TherapyEva Puy Vicente, Carolina Cuellar-García, Montserrat Martinez, et al.
Pageof 17

Showing results (101-110 of 167) with videos related to

Sort By:
Pageof 17
Transplantation and Cellular Therapy|November 10, 2021
Efficacy and Safety of Ruxolitinib in Steroid-Refractory/Dependent Chronic Graft-versus-Host Disease: Real-World Data and ChallengesSara Redondo, Albert Esquirol, Silvana Novelli, et al.
Physiological Genomics|June 20, 2013
SORCS1 contributes to the development of renal disease in rats and humansJozef Lazar, Caitlin C O'Meara, Allison B Sarkis, et al.
American Journal of Physiology. Renal Physiology|July 22, 2016
Inhibition of T-cell activation by the CTLA4-Fc Abatacept is sufficient to ameliorate proteinuric kidney diseaseMarcela Herrera, Magnus Söderberg, Alan Sabirsh, et al.
Journal of Cancer Research and Clinical Oncology|August 31, 2019
Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioningNiels Smedegaard Andersen, Martin Bornhäuser, Martin Gramatzki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 20, 2014
Mutation of Plekha7 attenuates salt-sensitive hypertension in the ratBradley T Endres, Jessica R C Priestley, Oleg Palygin, et al.
American Journal of Physiology. Renal Physiology|October 10, 2008
Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injuryJan Michael Williams, Albert Sarkis, Kimberly M Hoagland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2023
B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib TherapyJennifer A Woyach, Paolo Ghia, John C Byrd, et al.
Circulation. Cardiovascular Genetics|January 29, 2015
SH2B3 Is a Genetic Determinant of Cardiac Inflammation and FibrosisMichael J Flister, Matthew J Hoffman, Angela Lemke, et al.
European Journal of Immunology|June 20, 2006
IGHV gene insertions and deletions in chronic lymphocytic leukemia: "CLL-biased" deletions in a subset of cases with stereotyped receptorsChrysoula J Belessi, Frédéric B Davi, Kostas E Stamatopoulos, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 19, 2018
Chronic Lymphocytic Leukemia: Clinical Stages Maintain Their Prognostic Significance Over the Course of the Disease and Are Surrogates for Response to TherapyEva Puy Vicente, Carolina Cuellar-García, Montserrat Martinez, et al.
Pageof 17